by
Mathieu Calmont, Area Business Manager EMEA (Europe – Middle East – Africa),
France, and Kristin Sandersen Gretland, Technical Sales Manager, Borregaard,
Scandinavia, Norway
In many countries, shrimp aquaculture production is depressed by disease,
particularly caused by vibrio bacteria. Antibiotics, which have been used in
large quantities, are in many cases ineffective, or result in increased
virulence of pathogens. Formaldehyde products have been widely used, and
resistance behavior has started to appear in shrimp farming.
Vibrio parahaemolyticus and Vibrio harveyi have been described as the main
pathogens in shrimp species. These
pathogens cause serious infections and decreased productivity both in
hatcheries and ponds. In addition, this leads to reduced feed conversion and
reduced growth rate in surviving individuals.
Most bacterial aquatic diseases are related to vibrio bacteria. These bacteria
usually dominate the normal microflora of farmed and wild penaeoidean shrimp.
Bacteria will colonise in the digestive tract, release toxins, and eventually
destroy the digestive organ known as hepatopancreas. This is leading to high
mortality - up to 90 percent.
A new product, SoftAcid Aqua Deca, has been developed and optimised to be used
in all phases of shrimp production (from algae to growing phase). The product inhibits growth and biofilm
formation of vibrio, not allowing vibrio species to colonise the digestive
tracts of the shrimp. Shrimp feeding studies have shown positive results – with
higher survival rate, increase in biomass and reduction in feed conversion
cost.
Read more, HERE.
The Aquaculturists
No comments:
Post a Comment